Pfizer CEO Albert Bourla (L) and Moderna CEO Stéphane Bancel (Matthew Busch/Bloomberg via Getty Images; Nancy Lane/The Boston Herald via AP Images, Pool)
March 17, 2023 10:47 AM EDTUpdated 11:14 AM
People
Pharma

Pfiz­er's Bourla and Mod­er­na's Ban­cel saw com­pen­sa­tion bumps in 2022

Kyle LaHucik

Senior Reporter

More Big Phar­mas and hot­ly-watched biotechs have dis­closed the to­tal com­pen­sa­tion fig­ures for their ex­ec­u­tives, high­light­ing the pay pack­ages of Covid-19 be­he­moths, in­sulin mak­ers and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times